Waters Co. to Post Q3 2024 Earnings of $2.98 Per Share, Leerink Partnrs Forecasts (NYSE:WAT)

Waters Co. (NYSE:WAT) – Analysts at Leerink Partnrs raised their Q3 2024 EPS estimates for shares of Waters in a research note issued to investors on Tuesday, May 7th. Leerink Partnrs analyst P. Souda now expects that the medical instruments supplier will earn $2.98 per share for the quarter, up from their previous forecast of $2.93. The consensus estimate for Waters’ current full-year earnings is $11.89 per share. Leerink Partnrs also issued estimates for Waters’ Q4 2024 earnings at $4.16 EPS and Q4 2025 earnings at $4.42 EPS.

Other analysts also recently issued reports about the company. Evercore ISI increased their price objective on Waters from $320.00 to $340.00 and gave the company an “in-line” rating in a report on Thursday, April 4th. Barclays cut their price objective on Waters from $300.00 to $295.00 and set an “underweight” rating on the stock in a research note on Wednesday. TD Cowen increased their target price on shares of Waters from $350.00 to $358.00 and gave the company a “hold” rating in a research report on Wednesday. Stifel Nicolaus upped their price target on shares of Waters from $330.00 to $332.00 and gave the company a “hold” rating in a research report on Wednesday. Finally, Robert W. Baird lowered their price objective on Waters from $319.00 to $312.00 and set a “neutral” rating for the company in a research report on Wednesday. One research analyst has rated the stock with a sell rating and ten have given a hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $306.70.

Waters Stock Performance

Shares of WAT stock opened at $336.42 on Thursday. The business’s 50-day moving average price is $332.93 and its 200-day moving average price is $311.03. Waters has a 12 month low of $231.90 and a 12 month high of $363.80. The company has a current ratio of 2.22, a quick ratio of 1.57 and a debt-to-equity ratio of 2.00. The firm has a market capitalization of $19.95 billion, a price-to-earnings ratio of 31.01, a PEG ratio of 6.39 and a beta of 0.98.

Waters (NYSE:WAT) last released its quarterly earnings data on Tuesday, May 7th. The medical instruments supplier reported $2.21 earnings per share for the quarter, beating the consensus estimate of $2.10 by $0.11. Waters had a return on equity of 81.30% and a net margin of 21.72%. The company had revenue of $636.80 million for the quarter, compared to the consensus estimate of $635.57 million. During the same quarter last year, the business posted $2.49 EPS. Waters’s revenue for the quarter was down 7.0% on a year-over-year basis.

Insider Transactions at Waters

In other Waters news, Director Linda Baddour sold 500 shares of the stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $355.54, for a total transaction of $177,770.00. Following the sale, the director now owns 2,250 shares in the company, valued at $799,965. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 0.82% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the company. Indiana Trust & Investment Management CO bought a new stake in Waters in the 1st quarter worth approximately $25,000. Riverview Trust Co bought a new stake in Waters in the first quarter valued at approximately $28,000. Annis Gardner Whiting Capital Advisors LLC purchased a new stake in shares of Waters during the third quarter valued at approximately $33,000. Exchange Traded Concepts LLC purchased a new position in Waters during the 4th quarter valued at about $35,000. Finally, VisionPoint Advisory Group LLC increased its position in shares of Waters by 300.0% during the third quarter. VisionPoint Advisory Group LLC now owns 144 shares of the medical instruments supplier’s stock valued at $39,000 after buying an additional 108 shares during the period. Institutional investors own 94.01% of the company’s stock.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.